EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The possible role of Wnt/β‐catenin signalling in vitiligo treatment

Xiran Lin iD, Xianmin Meng, Jingrong Lin iD

Journal of the European Academy of Dermatology and Venereology · 2023-11 · 37 (11) · 2208-2221

DOI: 10.1111/jdv.19022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 07.04.2023. Verfasst von Xiran Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Vitiligo, Hypopigmentation. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 129 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is a common chronic skin disease which has an adverse impact on patients' life. Its pathogenesis is complex, involving autoimmunity and oxidative stress (OS). Autoimmunity leads to the loss of epidermal melanocytes and the formation of the depigmented patches of the disease. Treatment of vitiligo should control the exaggerated immune response to arrest the progress of active disease, and then promote melanocytes to repigmentation. Wnt/β‐catenin signalling pathway has been of recent interest in vitiligo. Wnt/β‐catenin signalling pathway is downregulated in vitiligo. Upregulation of Wnt/β‐catenin signalling possibly control vitiligo autoimmune response by protecting melanocyte from OS damage, inhibiting CD8 + T cell effector cell differentiation and enhancing Treg. Wnt/β‐catenin signalling plays a critical role in the melanocyte regeneration by driving the differentiation of melanocyte stem cells (McSCs) into melanocytes. Promoting Wnt/β‐catenin signalling can not only arrest the progress of active disease of vitiligo but also promote repigmentation. Some of the main effective therapies for vitiligo are likely to work by activating Wnt/β‐catenin signalling. Agents that can enhance the effect of Wnt/β‐catenin signalling may become potential candidates for the development of new drugs for vitiligo treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoHypopigmentationHumansbeta CateninMelanocytesEpidermis

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Department of Dermatology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Pathology and Laboratory Medicine, Axia Women's Health, Oaks, Pennsylvania, USA.

ORCID-Profile: Xiran Lin, Jingrong Lin

Zitieren

APA

Lin, X., Meng, X., & Lin, J. (2023). The possible role of Wnt/β‐catenin signalling in vitiligo treatment. Journal of the European Academy of Dermatology and Venereology, 37(11), 2208-2221. https://doi.org/10.1111/jdv.19022

Vancouver

Lin X, Meng X, Lin J. The possible role of Wnt/β‐catenin signalling in vitiligo treatment. Journal of the European Academy of Dermatology and Venereology. 2023;37(11):2208-2221. doi:10.1111/jdv.19022

BibTeX
@article{Lin2023,
  author = {Lin, Xiran and Meng, Xianmin and Lin, Jingrong},
  title = {The possible role of Wnt/β‐catenin signalling in vitiligo treatment},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  volume = {37},
  number = {11},
  pages = {2208--2221},
  doi = {10.1111/jdv.19022}
}
Kostenlos starten →